Table 2 Clinical characteristics of symptomatic CAD patients based on coronary angiography
|  | Coronary normal (n = 261) | Coronary lesion (n = 1255) | P |
|---|---|---|---|
Male (n%) | 74 (28.4) | 658 (52.4) | 0.000 |
Age (years) | 61 (56, 66) | 64 (59, 69) | 0.000 |
BMI (kg/m2) | 24.8 (22.9, 27.4) | 25.2 (23.4, 27.7) | 0.027 |
TyG index (n%) | 0.000 | ||
 T1 (lowest) | 107 (41) | 272 (21.7) | |
 T2 | 66 (25.3) | 313 (24.9) | |
 T3 | 51 (19.5) | 328 (26.1) | |
 T4 (highest) | 37 (17.2) | 342 (27.3) | |
SBP (mmHg) | 130 (120, 140) | 133 (122, 145) | 0.000 |
TC (mmol/L) | 4.6 (3.9, 5.2) | 4.4 (3.7, 5.2) | 0.016 |
LDL-C (mmol/L) | 2.8 (2.2, 3.4) | 2.7 (2.1, 3.3) | 0.313 |
HDL-C (mmol/L) | 1.2 (1.0, 1.4) | 1.1 (1.0, 1.3) | 0.000 |
PLT (*109/L) | 209 (182, 248) | 213 (183, 252) | 0.707 |
HbA1C (%) | 5.8 (5.6, 6.2) | 6.1 (5.7, 6.8) | 0.000 |
Hypertension (n%) | 134 (51.3) | 853 (68) | 0.000 |
Diabetes (n%) | 39 (14.9) | 420 (33.5) | 0.000 |
Smoking (n%) | 72 (27.6) | 517 (41.2) | 0.000 |
Use of antilipemic agents (n%) | 26 (10) | 327 (26.1) | 0.000 |
Use of antidiabetic agents (n%) | 28 (10.7) | 348 (27.7) | 0.000 |